Filing Details

Accession Number:
0001415889-23-004494
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-03-08 16:30:33
Reporting Period:
2023-03-06
Accepted Time:
2023-03-08 16:30:33
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1082554 United Therapeutics Corp UTHR Pharmaceutical Preparations (2834) 521984749
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1106578 A Martine Rothblatt C/O United Therapeutics Corporation
1040 Spring Street
Silver Spring MD 20910
Chairperson & Ceo No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2023-03-06 8,000 $113.08 8,130 No 4 M Direct
Common Stock Disposition 2023-03-06 1,087 $246.12 7,043 No 4 S Direct
Common Stock Disposition 2023-03-06 4,383 $247.10 2,660 No 4 S Direct
Common Stock Disposition 2023-03-06 2,349 $248.04 311 No 4 S Direct
Common Stock Disposition 2023-03-06 181 $248.65 130 No 4 S Direct
Common Stock Acquisiton 2023-03-07 8,000 $113.08 8,130 No 4 M Direct
Common Stock Disposition 2023-03-07 2,170 $237.01 5,951 No 4 S Direct
Common Stock Disposition 2023-03-07 2,718 $238.03 3,233 No 4 S Direct
Common Stock Disposition 2023-03-07 693 $239.18 2,540 No 4 S Direct
Common Stock Disposition 2023-03-07 1,009 $240.28 1,531 No 4 S Direct
Common Stock Disposition 2023-03-07 253 $240.85 1,278 No 4 S Direct
Common Stock Disposition 2023-03-07 109 $242.13 1,169 No 4 S Direct
Common Stock Disposition 2023-03-07 252 $243.42 917 No 4 S Direct
Common Stock Disposition 2023-03-07 469 $244.56 448 No 4 S Direct
Common Stock Disposition 2023-03-07 265 $245.36 183 No 4 S Direct
Common Stock Disposition 2023-03-07 6 $246.55 177 No 4 S Direct
Common Stock Disposition 2023-03-07 56 $248.03 121 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Options Disposition 2023-03-06 8,000 $0.00 8,000 $113.08
Common Stock Stock Options Disposition 2023-03-07 8,000 $0.00 8,000 $113.08
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
320,000 2013-12-31 2023-12-31 No 4 M Direct
312,000 2013-12-31 2023-12-31 No 4 M Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 166 Indirect By Spouse
Common Stock 644,183 Indirect By Trusts
Footnotes
  1. This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person. This plan will continue until the earlier of: (a) exhaustion of a tranche of 1,000,000 stock options that expire December 31, 2023; or (b) July 31, 2023.
  2. This transaction was executed in multiple trades at prices ranging from $245.52 to $246.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  3. This transaction was executed in multiple trades at prices ranging from $246.58 to $247.505. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  4. This transaction was executed in multiple trades at prices ranging from $247.60 to $248.45. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  5. This transaction was executed in multiple trades at prices ranging from $248.62 to $248.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  6. This transaction was executed in multiple trades at prices ranging from $236.56 to $237.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  7. This transaction was executed in multiple trades at prices ranging from $237.61 to $238.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  8. This transaction was executed in multiple trades at prices ranging from $238.61 to $239.57. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  9. This transaction was executed in multiple trades at prices ranging from $239.685 to $240.64. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  10. This transaction was executed in multiple trades at prices ranging from $240.71 to $241.21. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  11. This transaction was executed in multiple trades at prices ranging from $241.785 to $242.76. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  12. This transaction was executed in multiple trades at prices ranging from $242.905 to $243.71. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  13. This transaction was executed in multiple trades at prices ranging from $244.10 to $244.965. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
  14. This transaction was executed in multiple trades at prices ranging from $245.11 to $245.72. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.